Literature DB >> 377721

Prolonged kidney allograft survival with promethazine.

D C Dunn, J Wade.   

Abstract

The effects of promethazine hydrochloride have been investigated in a rabbit kidney allograft model. The drug was ineffective on its own, but if added to a protocol that induced partial suppression of rejection in 50% of recipients, its effect was dramatic. Allograft survival was prolonged from a control mean of 10.3 days to a mean of 26.3 days. One animal survived 2 1/2 months, and no other drug than promethazine was given after day 6. Promethazine and 6-methylprednisolone alone also prolonged allograft survival, but the results were significantly better if the recipient had been exposed to donor blood before grafting. The results suggest that promethazine is a useful adjuvant immunosuppressive drug. It could be beneficial in man.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377721

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  Antazoline as an adjuvant in immunosuppressive therapy in renal transplant patients.

Authors:  A Montandon; D Brügger; J Hodler
Journal:  Klin Wochenschr       Date:  1986-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.